Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Molecular Pathogenesis

Dissociation of Infectivity and Pathogenicity inBorrelia burgdorferi

Venetta Thomas, Juan Anguita, Swapna Samanta, Patricia A. Rosa, Philip Stewart, Stephen W. Barthold, Erol Fikrig
Venetta Thomas
Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Anguita
Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swapna Samanta
Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia A. Rosa
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Stewart
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen W. Barthold
Center for Comparative Medicine, Schools of Medicine and Veterinary Medicine, University of California, Davis, California 95616
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erol Fikrig
Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.5.3507-3509.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Clonal Borrelia burgdorferi N40 (cN40) passaged 75 times in vitro (N40-75) infects mice but does not cause disease. N40-75 passaged 45 times further in vitro (N40-120) was no longer infectious and lacked genes encoded on linear plasmids 38 and 28-1, among other differences. These data suggest that B. burgdorferi cN40, N40-75, and N40-120 have distinct phenotypes that can be used to dissect the genetic elements responsible for pathogenicity and infectivity.

Lyme borreliosis, which is caused byBorrelia burgdorferi, can result in infection and disease involving the skin, joints, and heart, both in humans and in experimental models (2, 3, 18, 27). Comparisons ofB. burgdorferi isolates cultured in vitro have helped to identify B. burgdorferi genes that may be associated with infectivity. Noninfectious B. burgdorferi isolates have been shown to lack, or have reduced expression of or mutations in, ospB, ospD, ospC, or vls, among other genes, and the loss of several plasmids, including linear plasmid (lp) 25, lp28.4, and circular plasmid 9 (5, 16, 19, 20, 24, 25, 28, 31-34). A direct cause and effect relationship has not yet been established for any single gene or plasmid: for example, some noninfectious B. burgdorferi B31 clones expressospD and other infectious clones do not (15, 19-21). Recent studies have also suggested an important role for lp28-1 in B. burgdorferi infectivity (14, 22). The genetic factors that contribute to B. burgdorferi infectivity and pathogenicity (i.e., the ability to cause arthritis and carditis) are likely to be both multifactorial and distinct.

Several B. burgdorferi isolates that were initially nonclonal have been shown to lose infectivity fairly quickly upon in vitro passage (19, 20, 25). In contrast, a clonal isolate of B. burgdorferi N40 (cN40) that is highly pathogenic in C3H/HeN (C3H) mice, causing severe arthritis and carditis, retains infectivity after multiple passages (1). However, cN40 passaged 75 times in vitro (N40-75) and individual N40-75 clones were infectious but nonpathogenic in mice, thereby enabling us to begin to dissociate these two processes (1). N40-75 also remained nonpathogenic when passaged one time through immunocompetent mice (data not shown), but the stability of this phenotype in vivo must be explored further, because N40-75 can cause disease in severe combined immunodeficient (SCID) mice (1). The inability of N40-75 to cause arthritis and carditis in immunocompetent mice has been associated with the lack of expression of several genes that are preferentially expressed in vivo rather than the loss of specific genetic material in DNA analyses or of antigens in protein profiles or immunoblots (1). We have now passaged N40-75 further to develop specific derivatives of the spirochete that are noninfectious in mice and that can be used to understand the differences that contribute to both the infectivity and pathogenicity of B. burgdorferi.

N40-75 passaged in vitro retained infectivity in C3H mice until passage 120 (N40-120). Spirochetes were passaged by cultivation in Barbour-Stoenner-Kelly II medium as described previously (1). Every five passages, the spirochetes were tested for their ability to infect mice; representative passaged isolates (i.e., N40-90, N40-105, and N40-120) are shown in Table1. When B. burgdorferiwas noted to lose infectivity (N40-120), the previous five individual passaged isolates were then also tested for infectivity, such as N40-119 (Table 1). Mice were intradermally inoculated with 104 N40-120 spirochetes in the dorsal midthorax, and 2 weeks later, skin, bladder, heart, and joints were examined forB. burgdorferi by using PCR, culture, and histopathology (Table 1) (1). Infection or disease was not evident in mice challenged with N40-120. Five individual N40-120 clones were also noninfectious in mice (data not shown). N40-120 remained noninfectious even when 107organisms were injected into C3H mice or when spirochetes were administered to immunodeficient C3H-scid mice.

View this table:
  • View inline
  • View popup
Table 1.

Noninfectious derivatives of B. burgdorferi N40

To identify the factors that correlate with infectivity of N40-120, protein profiles of cN40 and N40-120 were compared (Fig.1A). Previous studies have demonstrated that consistent differences between cN40 and N40-75 were not apparent from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or immunoblotting, in part because subclones of N40-75 had variable patterns of protein expression (1). Several protein bands were somewhat less intense in N40-120 than in cN40 on Coomassie blue-stained SDS–12% PAGE gels (Fig. 1A). In addition, cN40 had several bands between 26 to 35 kDa that were not as evident in N40-120 upon immunoblotting using sera fromB. burgdorferi cN40-infected mice (Fig. 1B). These studies suggested that specific genetic elements might have been lost in N40-120.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Characterization of noninfectious B. burgdorferi N40-120. (A) Coomassie blue-stained SDS-PAGE gel of cN40, N40-75, and N40-120. (B) Immunoblot of cN40 and N40-120 probed with sera from B. burgdorferi cN40-infected mice (needle inoculation with 104 spirochetes). Some potential differences are shown with arrows. (C) PCR analysis of DNA from cN40, N40-75, and N40-120. PCR was performed with primers specific forospA, ospC, bbk50, flaB, p21, erpT, ospD, bbj48, andbbj25. Amplified DNA was visualized by ethidium bromide incorporation. Reactions in which water served as the template were used as a control (Control). (D) Southern blot of cN40, N40-75, and N40-120 probed with horseradish peroxidase-labeled vls DNA fragment.

PCR of selected B. burgdorferi genes demonstrated the loss of some genes that are either antigenic or have been associated with infectivity. PCR was performed for 30 cycles with primers specific for each gene, as described previously (1). Several genes, including ospA (which is down-regulated during tick engorgement [6, 8]), ospC (which is up-regulated during tick feeding [26]),bbk50 (which is preferentially expressed in vivo [11]), flaB (which is involved in skeletal structure and motility [17]), and p21 (a member of the ospE-related protein [erp] gene family [7]), were present in cN40, N40-75, and N40-120 (Fig. 1C). The amplified p21 PCR product was lower in intensity in cN40 than in N40-120 but was always detectable in repeated assays. The ospD gene, which is on lp38 and encodes a 28-kDa protein, was not present in N40-120 (Fig. 1C). bbj25 andbbj48 (13), which are two additional genes on lp38, were also not evident in N40-120, suggesting that this plasmid had been lost in N40-120 (Fig. 1C). Previous studies have shown that infectivity does not correlate strictly with the presence ofospD (15, 19-21). We therefore assessed whether erpT, a gene that is preferentially expressed in deep tissues and is present on the vls-containing plasmid lp28-1, was present in N40-120 (10, 12, 13).erpT DNA was not detected in N40-120 (Fig. 1C). Thevls locus has been strongly correlated with infectivity (33, 34), and Southern blotting revealed that N40-120 lacked the vls gene locus, which is consistent with the loss of lp28-1 (Fig. 1D). PCR and Southern blotting demonstrated that N40-119 contained genes located on lp28-1 and lp38 (results not shown), indicating that these two plasmids were lost during the subsequent passage. These data provide initial insight into some of the genetic differences between cN40 and N40-120, but they are not meant to be comprehensive.

We have demonstrated that passaged isolates of B. burgdorferi N40—cN40, N40-75, and N40-120—can be distinguished with respect to infectivity and pathogenicity. The number of passages required to generate N40 spirochetes with alterations in infectivity suggests that previously infectious organisms can be converted into noninfectious spirochetes by the loss of genetic material but that conversion does not occur equally during all passages. TheseB. burgdorferi N40 descendants may provide new opportunities for targeted genetic manipulation of the spirochete that can then be studied in the murine model. Initial studies have demonstrated that cN40 and infectious clones derived from cN40 can be transformed by electroporation, although the frequency of transformation was approximately 100-fold lower than what was observed with a noninfectious clone of B. burgdorferi B31 (P. Rosa, unpublished results). Transformation of B. burgdorferi has previously only been demonstrated in noninfectiousB. burgdorferi B31 (4, 9, 23, 29). Recently, Stewart and his colleagues succeeded in transforming infectious spirochetes with a shuttle vector capable of autonomous replication in B. burgdorferi (30). These developments should facilitate efforts to define the contributions of specific B. burgdorferi genes to infection and disease.

The factors contributing to the ability of B. burgdorferi to infect the mammalian host and to cause specific disease manifestations, such as arthritis and carditis, are likely to be multifactorial. Both the diversity of the host response to the spirochete and the virulence of the incoming B. burgdorferi isolate may influence the outcome of exposure to this pathogen. B. burgdorferi cN40, N40-75, and N40-120 have well-defined phenotypes in the experimental murine model of Lyme disease. These organisms should prove useful for distinguishing the spirochete genotypes that are important for B. burgdorferi persistence throughout its life cycle and for the ability of this organism to cause disease that affects selected organ systems.

ACKNOWLEDGMENTS

Grants from the National Institutes of Health, Arthritis Foundation, and American Heart Association and a gift from SmithKline Beecham Biologicals supported this work. E. Fikrig is the recipient of a Burroughs Wellcome Clinical Scientist Award in Translational Research.

Notes

Editor: R. N. Moore

FOOTNOTES

    • Received 12 October 2000.
    • Returned for modification 18 December 2000.
    • Accepted 21 February 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anguita J.,
    2. Samanta S.,
    3. Revilla B.,
    4. Suk K.,
    5. Das S.,
    6. Barthold S. W.,
    7. Fikrig E.
    Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity.Infect. Immun.68200012221230
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Barthold S. W.,
    2. Beck D. S.,
    3. Hansen G. M.,
    4. Terwilliger G. A.,
    5. Moody K. D.
    Lyme borreliosis in selected strains and ages of laboratory mice.J. Infect. Dis.1621990133138
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Barthold S. W.,
    2. Persing D. H.,
    3. Armstrong A. L.,
    4. Peeples R. A.
    Kinetics of Borrelia burgdorferi: dissemination and evolution of disease following intradermal inoculation of mice.Am. J. Pathol.1631991263273
    OpenUrlWeb of Science
  4. 4.↵
    1. Bono J. L.,
    2. Elias A. F.,
    3. Kupko J. J.,
    4. Stevenson B.,
    5. Tilly K.,
    6. Rosa P.
    Efficient targeted mutagenesis in Borrelia burgdorferi.J. Bacteriol.182200024452452
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Carroll J. A.,
    2. Gherardini F. C.
    Membrane protein variations associated with in vitro passage of Borrelia burgdorferi.Infect. Immun.641996392398
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Coleman J. L.,
    2. Gebbia J. A.,
    3. Piesman J.,
    4. Degen J. L.,
    5. Bugge T. H.,
    6. Benach J. L.
    Plasminogen is required for efficient dissemination of Borrelia burgdorferi in ticks and for enhancement of spirochetemia in mice.Cell89199711111119
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Das S.,
    2. Barthold S. W.,
    3. Giles S. S.,
    4. Montgomery R. R.,
    5. Telford S. R.,
    6. Fikrig E.
    Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.J. Clin. Investig.991997987995
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. de Silva A. M.,
    2. Telford S. R.,
    3. Brunet L. R.,
    4. Barthold S. W.,
    5. Fikrig E.
    Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.J. Exp. Med.1831996271275
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Elias A. F.,
    2. Bono J. L.,
    3. Carroll J. A.,
    4. Stewart P.,
    5. Tilly K.,
    6. Rosa P.
    Altered stationary-phase response in a Borrelia burgdorferi rpoS mutant.J. Bacteriol.182200029092918
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Feng S.,
    2. Hodzic E.,
    3. Barthold S. W.
    Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.Infect. Immun.68200041694173
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Fikrig E.,
    2. Barthold S. W.,
    3. Sun W.,
    4. Feng W.,
    5. Telford S. R.,
    6. Flavell R. A.
    Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.Immunity61997531539
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Fikrig E.,
    2. Chen M.,
    3. Barthold S. W.,
    4. Anguita J.,
    5. Feng W.,
    6. Telford S. R.,
    7. Flavell R. A.
    Borrelia burgdorferi erpT expression in the arthropod vector and murine host.Mol. Microbiol.311999281290
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Fraser C. M.,
    2. Casjens S.,
    3. Huang W. M.,
    4. Sutton G. G.,
    5. Clayton R.,
    6. Lathigra R.,
    7. White O.,
    8. Ketchum K. A.,
    9. Dodson R.,
    10. Hickey E. K.,
    11. Gwinn M.,
    12. Dougherty B.,
    13. Tomb J. F.,
    14. Fleischmann R. D.,
    15. Richardson D.,
    16. Peterson J.,
    17. Kerlavage A. R.,
    18. Quackenbush J.,
    19. Salzberg S.,
    20. Hanson M.,
    21. van Vugt R.,
    22. Palmer N.,
    23. Adams M. D.,
    24. Gocayne J.,
    25. Venter J. C.,
    26. et al.
    Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.Nature3901997580586
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Labandeira-Rey M.,
    2. Skare J. T.
    Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1.Infect. Immun.692001446455
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Marconi R. T.,
    2. Samuels D. S.,
    3. Landry R. K.,
    4. Garon C. F.
    Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange.J. Bacteriol.176199445724582
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Masuzawa T.,
    2. Kurita T.,
    3. Kawabata H.,
    4. Yanagihara Y.
    Relationship between infectivity and OspC expression in Lyme disease Borrelia.FEMS Microbiol. Lett.1231994319324
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Motaleb M. A.,
    2. Corum L.,
    3. Bono J. L.,
    4. Elias A. F.,
    5. Rosa P.,
    6. Samuels D. S.,
    7. Charon N. W.
    Borrelia burgdorferi periplasmic flagella have both skeletal and motility functions.Proc. Natl. Acad. Sci. USA9720001089910904
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Nadelman R. B.,
    2. Wormser G. P.
    Lyme borreliosis.Lancet3521998557565
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Norris S. J.,
    2. Carter C. J.,
    3. Howell J. K.,
    4. Barbour A. G.
    Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.Infect. Immun.60199246624672
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Norris S. J.,
    2. Howell J. K.,
    3. Garza S. A.,
    4. Ferdows M. S.,
    5. Barbour A. G.
    High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi.Infect. Immun.63199522062212
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Probert W. S.,
    2. Lefebvre R. B.
    Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB or OspC but not OspD or the 83-kilodalton antigen.Infect. Immun.62199419201926
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Purser J. E.,
    2. Norris S. J.
    Correlation between plasmid content and infectivity in Borrelia burgdorferi.Proc. Natl. Acad. Sci. USA9720001386513870
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Rosa P.,
    2. Samuels D. S.,
    3. Hogan D.,
    4. Stevenson B.,
    5. Casjens S.,
    6. Tilly K.
    Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.J. Bacteriol.178199659465953
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Sadziene A.,
    2. Barbour A. G.,
    3. Rosa P. A.,
    4. Thomas D. D.
    An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo.Infect. Immun.61199335903596
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Schwan T. G.,
    2. Burgdorfer W.,
    3. Garon C. F.
    Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.Infect. Immun.56198818311836
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Schwan T. G.,
    2. Piesman J.,
    3. Golde W. T.,
    4. Dolan M. C.,
    5. Rosa P. A.
    Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.Proc. Natl. Acad. Sci. USA92199529092913
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Seiler K. P.,
    2. Weis J. J.
    Immunity to Lyme disease: protection, pathology and persistence.Curr. Opin. Immunol.81996503509
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Simpson W. J.,
    2. Garon C. F.,
    3. Schwan T. G.
    Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi.Microb. Pathog.81990109118
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Stevenson B.,
    2. Bono J. L.,
    3. Elias A.,
    4. Tilly K.,
    5. Rosa P.
    Transformation of the Lyme disease spirochete Borrelia burgdorferi with heterologous DNA.J. Bacteriol.180199848504855
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Stewart P.,
    2. Thalken R.,
    3. Bono J.,
    4. Rosa P.
    Isolation of a circular plasmid region sufficient for autonomous replication and transformation of infectious Borrelia burgdorferi.Mol. Microbiol392001714722
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Xu Y.,
    2. Kodner C.,
    3. Coleman L.,
    4. Johnson R. C.
    Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.Infect. Immun.64199638703876
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Yang X.,
    2. Goldberg M. S.,
    3. Popova T. G.,
    4. Schoeler G. B.,
    5. Wikel S. K.,
    6. Hagman K. E.,
    7. Norgard M. V.
    Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia burgdorferi.Mol. Microbiol.37200014701479
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Zhang J. R.,
    2. Hardham J. M.,
    3. Barbour A. G.,
    4. Norris S. J.
    Antigenic variation in Lyme disease borreliae by promiscuous recombination of Vmp-like sequence cassettes.Cell891997275285
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Zhang J. R.,
    2. Norris S. J.
    Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi.Infect. Immun.66199836893697
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Dissociation of Infectivity and Pathogenicity inBorrelia burgdorferi
Venetta Thomas, Juan Anguita, Swapna Samanta, Patricia A. Rosa, Philip Stewart, Stephen W. Barthold, Erol Fikrig
Infection and Immunity May 2001, 69 (5) 3507-3509; DOI: 10.1128/IAI.69.5.3507-3509.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dissociation of Infectivity and Pathogenicity inBorrelia burgdorferi
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dissociation of Infectivity and Pathogenicity inBorrelia burgdorferi
Venetta Thomas, Juan Anguita, Swapna Samanta, Patricia A. Rosa, Philip Stewart, Stephen W. Barthold, Erol Fikrig
Infection and Immunity May 2001, 69 (5) 3507-3509; DOI: 10.1128/IAI.69.5.3507-3509.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Borrelia burgdorferi Group

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522